| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/18/1996 | CA2207252A1 Inhibitors of prenyl transferases |
| 07/17/1996 | EP0721957A1 Compound ge3 |
| 07/17/1996 | EP0721510A1 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 07/17/1996 | EP0721504A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
| 07/17/1996 | EP0721470A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/17/1996 | EP0721465A1 Glutathione s-transferase-activated compounds |
| 07/17/1996 | EP0721463A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 07/17/1996 | EP0721457A1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity |
| 07/17/1996 | EP0721456A1 Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721447A1 Anthracene derivatives for use as anticancer agent or dye |
| 07/17/1996 | EP0721352A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/17/1996 | EP0721345A1 Prostatic cancer vaccine |
| 07/17/1996 | EP0721344A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721341A1 Cloning and characterization of the complete mage-1 gene |
| 07/17/1996 | EP0721336A1 Benzazole compounds for use in therapy |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | EP0721328A1 Camptothecin formulations |
| 07/17/1996 | EP0711301A4 Processes and intermediates for phosphorous-containing covalent linkages |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1126726A Process for N-acyl-5-fluorocytidine derivatives |
| 07/17/1996 | CN1126723A Preparation of derivative of 4-deoxcide-4-surface-podocyllin poison |
| 07/16/1996 | US5536850 Substance DC114-A1 |
| 07/16/1996 | US5536848 Bioactive acetogenins and derivatives |
| 07/16/1996 | US5536847 Antitumor agents |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536747 Enzyme inhibitors |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536722 Triazine derivatives for enhancing antitumor activity |
| 07/16/1996 | US5536713 Osteoporosis |
| 07/16/1996 | US5536642 Cell-associated interleukin-2 receptor a expression |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/16/1996 | CA2085520C Stable hexahydrate of etoposide 4'-phosphate disodium salt |
| 07/16/1996 | CA2029616C Chemical compound exhibiting anti-bacterial and anti-tumour activity |
| 07/11/1996 | WO1996021026A1 POLYMERASE δ MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020715A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 07/11/1996 | WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | WO1996020701A1 Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996015128A3 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/10/1996 | EP0720986A1 Platinum complex and malignant tumor treating drug containing the same |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720635A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720619A1 Selectin binding glycopeptides |
| 07/10/1996 | EP0720601A1 Gastrin and cck receptor ligands |
| 07/10/1996 | EP0720597A1 Triaryl-ethylene derivatives for use in therapy |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | CN1126473A Carbazole derivatives with 17,20-lyase-inhibiting activity |
| 07/10/1996 | CN1126212A Camptothecin derivatives, preparations thereof and antitumor agents |
| 07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |
| 07/10/1996 | CN1032235C Method for producing kedarcidine antitumor chromophore |
| 07/09/1996 | US5534625 Melamine derivatives for use in the treatment of cancer |
| 07/09/1996 | US5534539 Antitumor agents |
| 07/09/1996 | US5534531 Anticancer agents |
| 07/09/1996 | US5534254 Biosynthetic binding proteins for immuno-targeting |
| 07/09/1996 | CA1338445C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 07/04/1996 | WO1996020217A1 Monoclonal antibody |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020180A1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996019996A1 NEW USES OF INDOLO-[2,3b]-QUINOXALINES |
| 07/04/1996 | WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism |
| 07/04/1996 | WO1996019988A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 07/04/1996 | WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208444A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207548A1 Piperazine 2,5-dione derivatives as modulators of multi-drug resistance |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/03/1996 | EP0719859A1 Anti-alpha V-integrin monoclonal antibody |
| 07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 07/03/1996 | EP0719777A2 N-oxotetrahydro-beta-carbolines |
| 07/03/1996 | EP0719546A1 LUV comprising saturated phospholipids and method of making the same |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719332A1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0719271A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents |